Interim 2023/24 influenza A vaccine effectiveness: VEBIS European primary care and hospital multicentre studies, September 2023 to January 2024Marine Maurel, Adele McKenna, Adam Meijer et al.|Eurosurveillance|2024Cited by 50
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022Angela Rose, Patricia Bruijning‐Verhagen, Nathalie Nicolay et al.|Eurosurveillance|2023Cited by 18
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Alpha- and Delta-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021Angela Rose, Regina Demlová, Nathalie Nicolay et al.|Eurosurveillance|2023Cited by 4
Vaccine effectiveness against hospitalisation with COVID-19 prior to and during Delta circulation in Europe in adults aged 30 yrs and over: I-MOVE-COVID-19 and ECDC hospital networks, JanuaryDecember 2021Angela Rose, Sabrina Bacci, Nathalie Nicolay et al.|Lithuanian University of Health Sciences|2022Cited by 0